Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4594217 | 0.94 | ALDH1A1 (0.41) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL27938085 | 0.78 | CA2 (0.42) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL4594767 | 0.77 | ALDH1A1 (0.43) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL5709911 | 0.74 | KCNH2 (0.45) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL10081832 | 0.74 | CA2 (0.42) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL21925352 | 0.74 | CA2 (0.42) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL28763161 | 0.74 | CA2 (0.42) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL14976954 | 0.73 | CA2 (0.41) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL11805953 | 0.73 | CA2 (0.41) | ALDH1A1LMNAGAATSHRCYP1A2 | |
| SCHEMBL10775543 | 0.73 | CA2 (0.41) | ALDH1A1LMNAGAATSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1417209-B1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORP (US) | 2008-01-16 | — | — | EP | claimed |
| EP-1417209-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | Crompton Corporation (US) | 2004-05-12 | — | — | EP | claimed |
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION, A CORPORATION OF THE STATE OF DELAWARE | 2003-04-03 | — | — | US | claimed |
| WO-2003014130-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORPORATION (US) | 2003-02-20 | — | — | WO | claimed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | claimed |
| EP-1417209-B1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORP (US) | 2008-01-16 | — | — | EP | disclosed |
| EP-1417209-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | Crompton Corporation (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION, A CORPORATION OF THE STATE OF DELAWARE | 2003-04-03 | — | — | US | disclosed |
| WO-2003014130-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORPORATION (US) | 2003-02-20 | — | — | WO | disclosed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | ROS1, POLR1A, ACP1 | ALDH1A1 1573/4885LMNA 2386/4885GAA 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.